phase readout
saveNCT05738486: A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
ACTIVE_NOT_RECRUITINGupdated 10m ago
community read0 votes
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
view source ↗
comments(0)
5-min edit window · permanent after that